Sunshine Biopharma (SBFM) Other Operating Expenses (2016 - 2025)

Sunshine Biopharma's (SBFM) quarterly Other Operating Expenses came in at -$7.0 in Q4 2025, up 99.93% on a QoQ basis from -$10250.0 in Q3 2025.

Sunshine Biopharma (SBFM) Other Operating Expenses (2016 - 2025) Analysis & Trends

Sunshine Biopharma (SBFM) has 2 years of Other Operating Expenses data on file, last reported at -$7.0 in Q4 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to -$7.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$10257.0 (changed N/A YoY) and the FY2025 annual result came in at -$10257.0, changed N/A from the prior year.
Other Operating Expenses rose to -$7.0 in Q4 2025, from -$10250.0 in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of -$7.0 in Q4 2025 to a low of -$10250.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Sunshine Biopharma	1.53 Mn	-12.22 Mn	2.43 Mn

Download Data